Store

Home
Haupt Pharma Wolfratshausen GmbH
Wolfratshausen Nov 2022 483

483 Document: Haupt Pharma Wolfratshausen GmbH, Nov 15, 2022

Guerlain Ulysse, FDA Investigator
Xiaokuang Lai, FDA Investigator

FDANews 483 Haupt Pharma Wolfratshausen GmbH Nov 15 2022 top

Guerlain Ulysse FDA Investigator Xiaokuang Lai FDA Investigator

On Nov 15, 2022, the FDA inspected Haupt Pharma Wolfratshausen GmbH's Wolfratshausen site. Explore the inspectional observations.

Haupt Pharma Wolfratshausen GmbH

483 Document

Issued: Nov 15, 2022

Details

Human DrugsInspection
Wolfratshausen / Germany
9 days

Available for Download - $199

[email protected]
+1 (650) 646-4996

About

About Us
Terms of Service
Privacy Policy
Support

GMP Resources

FDA Inspections DB

FDA Form 483 Database

Document Review

Related Apps

Quality Regulatory Intelligence

Redica Platform

Formerly FDAzilla, Redica is a data analytics platform built for the life sciences to improve product quality and reduce regulatory risk.

Clinical Trials Analytics

Clincosm

Marketplace connecting patients to clinical trials to accelerate patient recruitment is accelerating medicine

Productivity

CalendarCrush

App for calendar-driven people to account and bill for their time

Spectator Sports

BlitzSports

Score Clock App for youth sports parents asked to be time-keeper. This is the scorekeeping of the future.

Copyright © 2007 - 2024 Zymergi, Inc.